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An immature intestinal epithelial barrier may predis-
pose infants and children to many intestinal inflam-
matory diseases, such as infectious enteritis, inflam-
matory bowel disease, and necrotizing enterocolitis.
Understanding the factors that regulate gut barrier
maturation may yield insight into strategies to pre-
vent these intestinal diseases. The claudin family of
tight junction proteins plays an important role in
regulating epithelial paracellular permeability. Previ-
ous reports demonstrate that rodent intestinal barrier
function matures during the first 3 weeks of life. We
show that murine paracellular permeability markedly
decreases during postnatal maturation, with the most
significant change occurring between 2 and 3 weeks.
Here we report for the first time that commensal
bacterial colonization induces intestinal barrier func-
tion maturation by promoting claudin 3 expression.
Neonatal mice raised on antibiotics or lacking the
toll-like receptor adaptor protein MyD88 exhibit im-
paired barrier function and decreased claudin 3 ex-
pression. Furthermore, enteral administration of ei-
ther live or heat-killed preparations of the probiotic
Lactobacillus rhamnosus GG accelerates intestinal
barrier maturation and induces claudin 3 expression.
However, live Lactobacillus rhamnosus GG increases
mortality. Taken together, these results support a vital
role for intestinal flora in the maturation of intestinal
barrier function. Probiotics may prevent intestinal
inflammatory diseases by regulating intestinal tight
junction protein expression and barrier function. The
use of heat-killed probiotics may provide therapeutic
benefit while minimizing adverse effects. (Am J
Pathol 2012, 180:626–635; DOI: 10.1016/j.ajpath.2011.10.025)
626Impaired or immature barrier function plays a key role in
the pathogenesis of many intestinal inflammatory dis-
eases of newborns and children, such as idiopathic in-
flammatory bowel disease (IBD),1,2 infectious enteritis, or
necrotizing enterocolitis (NEC).3–6 Tight junctions (TJs)
maintain separation of tissue compartments by sealing
the intercellular space while regulating paracellular per-
meability.7,8 During early postnatal maturation, the intes-
tinal barrier tightens and becomes more selectively per-
meable in both premature neonates9,10 and neonatal
animal models.11–14 Although dietary and trophic factors,
such as epidermal growth factor,15 and hormonal factors,
such as endogenous glucocorticoids,16 are involved with
postnatal intestinal maturation, other factors are likely to
play an important role in regulating barrier tightening in
the immature gut. Commensal bacteria, which normally
colonize the murine gut during the first several weeks
of postnatal life,17 induce expression of genes that
improve intestinal barrier function, whereas abnormal
bacterial colonization may disrupt this process and
contribute to the development of host diseases.18 Ne-
onates with abnormal intestinal microbial composition
may be predisposed to NEC, IBD, or infectious enteritis
as the result of a failure in postnatal maturation of this
critical protective barrier. The immature neonatal intes-
tinal barrier may fail to prevent systemic entry of mi-
crobes or microbial products and other toxins from
within the gut lumen, leading to intestinal inflammation
and injury.10,19–21 Indeed, preterm infants with altered
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more likely to develop NEC,22,23 and abnormal bacte-
rial colonization is implicated in the pathogenesis of
IBD.1 Furthermore, probiotics composed of commen-
sal bacteria have shown promise in reducing the inci-
dence and severity of NEC,4 IBD,24 and infectious di-
arrhea25 in infants and children.
Commensal bacterial signaling through toll-like recep-
tors (TLRs) is vital in maintaining the intestinal barrier.26 In
addition, alterations in TJ protein expression have con-
tributed to impaired barrier function in both IBD27 and
rodent models of NEC.28,29 To determine how acquisition
of commensal flora in the preterm infant may influence
the ontogeny of intestinal barrier function, as regulated by
TJ proteins, we modeled preterm human intestinal epi-
thelia using the neonatal mouse. Neonatal murine intes-
tinal epithelia are relatively immature at birth when com-
pared with term human epithelia, and murine intestinal
epithelia at 2 weeks postnatally resemble that of a human
at 24 gestational age.30 In addition, the murine gut ac-
quires its complement of flora, beginning at approxi-
mately 2 weeks postnatal age.17 Consistent with previous
developmental studies13,31 in rodents, we demonstrate
that the tightness of the intestinal epithelial barrier, as
measured by decreased paracellular permeability, ma-
tures over time, with the most significant change occur-
ring at 3 weeks of life.
Claudins, a key component of TJs, demonstrate strik-
ing changes in postnatal expression and localization.32
Here we report for the first time that intestinal barrier
function and intestinal expression and localization of
claudin 3 may be regulated by signaling from gut flora.
Mature expression and localization of claudin 3 occurs at
3 weeks in the postnatal mouse, coincident with matura-
tion in gut permeability. MyD88 null and antibiotic-raised
mice both demonstrate impairment in barrier function
with deficient expression of claudin 3. Finally, we report
that maturation of both gut barrier function and claudin
3 expression can be induced by probiotic administra-
tion. Neonatal mice gavage fed Lactobacillus rhamno-
sus GG (LGG) exhibit increased claudin 3 expression
and a dose-dependent acceleration of postnatal bar-
rier maturation. In addition, heat-killed LGG is able to
preserve the therapeutic effect of high-dose LGG while
reducing associated mortality. These results indicate
that intestinal barrier function, as regulated by TJ pro-
tein expression, can be influenced by gut flora. Probi-
otics may act to prevent intestinal diseases in neonates
and children by improving intestinal barrier function
through induction of appropriate TJ protein expression
and localization.
Materials and Methods
Mice
All animal experiments were approved by the Institutional
Animal Care and Use Committee at Emory University
(Atlanta, GA). C57BL/6J mice were bred in an animal
facility at Emory University. MyD88/ mice, originallygenerated by Shizuo Akira (Osaka, Japan), were exten-
sively backcrossed onto a C57BL/6 background, as pre-
viously described.33 Tissue samples were harvested at
various time points, ranging from embryonic day (E) 18
using timed-pregnant mice to adult (aged 8 weeks). Mice
were euthanized by cervical dislocation or decapitation
after CO2 anesthesia. The distal third of the small intes-
tine was immediately frozen for protein assays, placed in
RNAlater (Qiagen, Valencia, CA), or frozen in Tissue-Tek
Optimal Cutting Temperature medium (Sakura, Torrance,
CA) for histological staining.
Antibiotic Treatment
To prevent bacterial colonization of neonatal mice, adult
males and females were separated and treated for 3
weeks with neomycin (1 g/L), vancomycin (0.5 g/L), am-
picillin (1 g/L), and metronidazole (1g/L) in drinking water
to deplete commensal flora, as previously described.26
Kool-Aid Mix (20 mg/mL) (Kraft Foods, Glenview, IL) was
added to drinking water to promote consumption, as
previously described.34 Antibiotic solution was passed
through a 0.45 mol/L sterile filter (Millipore, Billerica, MA)
and replaced two to three times per week. After 3 weeks,
male and female mice were combined for mating and anti-
biotic water was continued. Cecal images were obtained
and compared between antibiotic-treated and control mice
as a marker for prevention of bacterial colonization (see
Supplemental Figure S1 at http://ajp.amjpathol.org), be-
cause cecal enlargement is characteristic of germ-free
mice.35 Enlargement of the cecum is attributed to hydro-
tropic mucus and retention of water, which is a conse-
quence of the absence of mucolytic bacteria.30
LGG Experiments
LGG (American Type Culture Collection, Manassas, VA)
was prepared in overnight culture, as previously de-
scribed,36,37 then washed and concentrated in PBS.
Mice were gavage fed PBS, with or without LGG [1  107
to 1  109 colony-forming units (CFU) per day], in an
equal volume daily for 7 days beginning at the age of 1
week. Heat-killed LGG was prepared by exposing the
concentrated LGG culture (1  109 CFU) to 70°C for 30
minutes. Heat-killed samples were examined by plating
on MRS media (Becton Dickinson, Franklin Lakes, NJ)
under anaerobic conditions and direct visualization by
light microscopy to confirm nonviability without disruption
of cell wall architecture. To visualize fluorescent LGG
within prepared sections of the neonatal distal small in-
testine by confocal microscopy, the bacterium was
stained with the fluorescent amine-reactive dye Cell
Trace Far Red DDAO-SE (catalog #C34553, Invitrogen,
Carlsbad, CA). Briefly, an overnight culture of LGG,
grown in liquid MRS media, was washed twice and
resuspended in 1 mL of PBS at a concentration of 1 
109 CFU/mL. The DDAO-SE dye was resuspended in
dimethyl sulfoxide, and 12.5 g was added to the
washed and resuspended LGG. After oral gavage ad-
ministration of LGG at a concentration of 1  109 CFU,
the distal small intestine was harvested and frozen in
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paraformaldehyde and permeabilized with Triton X-100.
Tissue sections were stained with Alexa Fluor 488 phal-
loidin (A12379; Invitrogen). Immunofluorescent localiza-
tion was evaluated by confocal microscopy (model
LSM510; Zeiss, Oberkochen, Germany).
Claudin Histological Staining
Frozen tissue sections (6 m thick) of distal small in-
testine were fixed in 100% ethanol at 20°C for 20
minutes. Sections were stained with primary rabbit an-
ti-claudin 3 (34-1700, Invitrogen) at a 1:500 dilution for
1 hour, followed by secondary anti-rabbit IgG (488 nm)
at 1:500 (A11008; Invitrogen) for 1 hour. Nuclei were
counterstained with TO-PRO (T3605; Invitrogen) for 2.5
minutes. Immunofluorescent localization was evalu-
ated by confocal microscopy (model LSM510; Zeiss).
Intestinal Permeability Assays
Barrier function was evaluated by measuring in vivo para-
cellular permeability to fluorescent-labeled dextran, as
previously described.38 Briefly, mice were fasted for 4.5
hours and then gavage fed 22 L/g of 22 g/L fluores-
cein isothiocyanate–labeled 4.4-kDa dextran (FD4;
Sigma, St Louis, MO). Serum was obtained 1 to 5 hours
after gavage administration by terminal cardiac puncture
(mice aged 2 weeks) or decapitation (mice aged 1
week) after CO2 anesthesia. The serum FD4 concentra-
tion was calculated by comparing samples with serial
dilutions of known standards using Synergy HT fluorime-
ter (BioTek, Winooski, VT) with excitation at 485 nm and
emission at 530 nm. A gain of 50 was used for all exper-
iments.
Western Blot/Protein Analysis
Intestinal tissue was prepared for Western blot analysis in
radioimmunoprecipitation assay lysis buffer, as previously
described.36 Samples were resolved by SDS-polyacryl-
amide gels and transferred to nitrocellulose by electro-
blotting. Membranes were probed with primary anti-oc-
cludin (71–1500; Invitrogen), anti-claudin 3 (34–1700;
Invitrogen), and anti-claudin 7 (34–9100; Invitrogen) at
1:500 and secondary goat anti-rabbit IgG (HL)–horse-
radish peroxidase (G21234; Invitrogen) at 1:1000. Equal
amounts of protein (20 g) were loaded in each lane, as
determined by the Bradford protein assay. Band densi-
tometry analysis was performed using ImageJ software
(NIH, Bethesda, MD) and normalized to occludin expres-
sion.
Evaluation of mRNA Expression
RNA was extracted using the RNeasy Mini Kit (Qiagen,
Valencia, CA) with on-column DNase digestion using the
RNAase-Free DNase set (Qiagen), per manufacturer’s
protocols. All RNA had A260/A280 and A260/A230 ratios
between 1.8 and 2.2. Reverse transcription was per-formed with 0.5 g RNA using the QuantiTect Reverse
Transcription Kit (Qiagen). Two-step quantitative real-
time PCRs were performed in duplicate for the develop-
mental survey of TJ protein expression and in triplicate for
all other assays, with normalization to 18s using the
QuantiTect SYBR Green PCR Kit (Qiagen). Gene expres-
sion was compared between samples by using the
2CT method.39 Primers were designed using Beacon
Design software (Bio-Rad, Hercules, CA) and OligoAna-
lyzer (IDT Technologies, Coralville, IA). Full primer se-
quences are available by request.
Statistical Analysis
Student’s t-tests (two groups) or an analysis of variance
with a post hoc Tukey’s multiple-comparison test (more
than two groups) was used where appropriate. In in-
stances in which data demonstrated a nongaussian dis-
tribution, a Mann-Whitney U-test (two groups) or a
Kruskal-Wallis with Dunn’s multiple-comparison test
(more than two groups) was used where appropriate. A
log-rank Mantel-Cox test was used to compare survival.
Prism Version 5 for Windows (GraphPad, La Jolla, CA)
was used for all statistical analysis. P  0.05 was con-
sidered significant. Bars depict mean values, with error
bars representing a single measure (SEM).
Results
Murine Intestinal Epithelial Barrier Tightens by
3 Weeks Postnatal Age
Intestinal epithelial barrier function develops postnatally
in the neonatal mouse, with the 2-week-old mouse dem-
onstrating similar intestinal epithelial maturity as a 24-
week gestational age human.30 Thus, the neonatal mu-
rine gut is often used to model premature human
intestines.36,37,40–42 To characterize the ontogeny of gut
barrier function, we measured in vivo intestinal permea-
bility to 4.4kDa dextran FD4 in the neonatal mouse during
the first 8 weeks of life. FD4 is a selective marker for
paracellular permeability and has been used to evaluate
both intestinal permeability19 and TJ function.43 First, to
optimize our assay for age-related differences in intesti-
nal transit time, we measured serum FD4 dextran con-
centrations 1 to 5 hours after oral gavage administration
(Figure 1A). Serum FD4 dextran peaked at 5 hours after
gavage in 2-week-old mice, at 3 to 5 hours in 3-week-old
mice, and at 4 hours in adult mice. Thus, all further
studies evaluating the development of intestinal epithe-
lial barrier function and paracellular permeability were
assayed in mice 5 hours after gavage administration of
FD4. Consistent with the idea that the 3-week-old
mouse intestine resembles the maturity of a term hu-
man intestine, we found significant maturation in gut
barrier function (as measured by a fourfold decline in
intestinal permeability to FD4 dextran) between 2 and 3
weeks (serum FD4 dextran, 14.93.3 and 3.80.8,
respectively; P  0.01), with continued decline there-
after (Figure 1B). These results indicate that the critical
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between 2 and 3 weeks of postnatal life in the neonatal
mouse and that 2-week-old mice may be used to study
the role of immature barrier function in premature in-
testinal diseases, such as NEC.
Claudin 3 Gene Expression Peaks at 3 Weeks in
the Murine Intestine
Alterations in TJ protein expression contribute to im-
paired barrier function in both IBD27 and rodent models
of NEC.28 To identify candidate TJ proteins that may play
a key role in maturation of intestinal barrier function, we
initially quantified intestinal mRNA expression of a panel
of TJ proteins during the first 8 weeks of murine life.
Several TJ proteins, including claudins 3, 7, and 13,
demonstrated 3- to 11-fold increases in mRNA expres-
sion from 2 days to 3 weeks of age (Figure 2A). Based on
these findings, we chose to further characterize the de-
velopmental mRNA and protein expression of claudins 3
and 7, because they may play a role in tightening of
epithelial barriers.44,45 We demonstrate that both claudin
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Figure 1. Murine intestinal epithelial barrier tightens by 3 weeks of postnatal
age. A: Time course of intestinal permeability as determined by serum FD4
concentration measured 1 to 5 hours after oral gavage in mice at the ages of
2 and 3 weeks and in adult mice. Data are the mean SEM from at least three
experimental repeats per condition. **P  0.01 versus the 1-hour time point.
B: Ontogeny of intestinal permeability, as measured by serum FD4 concen-
tration measured 5 hours after gavage administration during the first 8 weeks
of life. Data are the mean  SEM from at least three experimental repeats per
condition. *P  0.05, **P  0.01, and ***P  0.001 versus the 2-week time
point.3 and 7mRNA expression peaked at 3 weeks of postnatalage (Figure 2, B and C), the same age at which intestinal
permeability in the developing postnatal gut significantly
decreased (Figure 1A). However, the developmental in-
crease in claudin 7 mRNA expression was more variable.
These results indicate that claudins 3 and 7 may play a
key role in the postnatal maturation of murine intestinal
barrier function.
Mature Claudin 3 Protein Expression and
Localization Occurs at 3 Weeks in the
Murine Gut
To further evaluate the potential relevance of these two
candidate TJ proteins to maturation of intestinal barrier
function in the 3-week-old mouse, we measured the ex-
pression of intestinal claudins 3 and 7 by immunoblot
analysis. Protein levels of claudin 3 (Figure 3, A and C)
demonstrate dramatic increases beginning at 3 weeks
postnatal age, whereas expression of occludin, another
tetraspan TJ protein, remains relatively constant through-
out postnatal development (Figure 3, A and B). In con-
trast, protein levels of claudin 7 (Figure 3, B and D)
demonstrate no significant developmental changes. Based
on the significant increase in claudin 3 expression at 3
weeks postnatal age, we hypothesized that claudin 3 was
a potential mediator of postnatal decreases in paracellu-
lar permeability seen at 3 weeks of age and selected this
candidate TJ protein for further study.
Next, we characterized intestinal claudin 3 localiza-
tion by immunofluorescent staining and confocal mi-
croscopy during the first 8 weeks of murine life (Figure
3E). Coincident with increases in both mRNA expres-
sion and protein levels, claudin 3 demonstrates mature
protein localization at 3 weeks postnatal age, with sim-
ilar localization as adult mice. Claudin 3 remained lo-
calized in the TJs of crypt epithelium in younger mice
(2 days and 2 week) and transitioned to additional
expression in the mature villous epithelial cells begin-
ning at the age of 3 weeks. These results suggest that
appropriate localization and protein levels of claudin 3
may play a key role in maturation of the intestinal bar-
rier in the developing neonatal mouse.
Maturation of Intestinal Claudin 3 Expression
and Barrier Function Is MyD88 Dependent
Commensal bacterial signaling through TLRs is vital in
maintaining the intestinal barrier.26 Mice with significantly
reduced intestinal commensal bacteria (mice treated with
broad-spectrum antibiotics) and mice lacking a key
adaptor molecule for TLR signaling (MyD88/ mice)
exhibit exaggerated responses to intestinal injury.26 Fur-
thermore, studies46 indicate that TLR signaling, specifi-
cally through TLR-2, may play a key role in TJ protein
expression and epithelial barrier maturation and protect
against TJ disruption in murine colitis. To determine
whether acquisition of gut flora, occurring during the first
several weeks of murine life,17 induces expression of
claudin 3 through microbial interaction with TLRs, we
compared protein expression of claudin 3 in wild-type
ce. B an
t experi
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antibiotic-raised wild-type mice at 3 weeks of life. Three-
week-old MyD88/ and antibiotic-raised wild-type mice
exhibit decreased and immature expression of claudin 3,
with attenuated immunofluorescent staining in the TJs of
surface epithelial cells (Figure 4A). In addition, de-
creased claudin 3 protein levels were observed by using
Western blot analysis (Figure 4B). The immature expres-
sion of claudin 3 appears to be transcriptionally regulated
with decreased mRNA expression (Figure 4C) noted in
MyD88/ and antibiotic-raised mice at 3 weeks of life
Figure 2. Claudin 3 gene expression peaks at 3 weeks in the murine intes
changes in expression in murine intestines collected during the first 8 weeks
induction when comparing mRNA levels in 3-week-old versus 2-day-old mi
are expressed as fold change (mean  SEM from at least three independen
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Figure 3. Mature claudin 3 protein expression and localization occurs at 3
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Immature localization is noted primarily along the crypts in 2-day-old and 2-week
experiments.compared with control mice. More important, MyD88/
and antibiotic-raised mice also demonstrate immature
barrier function compared with control mice with signifi-
cantly increased FD4 intestinal permeability seen in
MyD88/ mice (Figure 4D). The trend toward increased
permeability in antibiotic-raised mice was associated
with increased variability in this group. These results in-
dicate that MyD88-dependent TLR signaling by commen-
sal bacteria may play a key role in the maturation of
neonatal murine intestinal barrier function through induc-
tion of claudin 3 expression.
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Induction of Claudin 3
Delayed or inappropriate intestinal bacterial colonization
has been implicated in the pathogenesis of NEC22,47 and
IBD.1 Probiotics containing commensal bacterial spe-
cies, such as Lactobacillus or Bifidobacterium, have re-
duced the incidence and severity of NEC.4 Probiotic ad-
ministration may act by normalizing microbial populations
or by directly improving host defense mechanisms. Spe-
cifically, probiotics containing commensal bacteria may
strengthen intestinal barrier function, which, in turn, may
reduce systemic entry of gut luminal microbes or toxins.
Our group has previously demonstrated that the probiotic
LGG augments host intestinal defense by promoting cy-
toprotective gene expression.37 To determine whether
LGG can similarly improve epithelial barrier function in
the immature murine gut, we compared intestinal claudin
3 expression and barrier function in 2-week-old mice
pretreated with enterally administered live LGG, heat-
killed LGG, or carrier control. Two-week-old mice gavage
fed live or heat-killed LGG at 1  109 CFU/day (for 1
week) demonstrated significantly improved barrier func-
tion with decreased intestinal paracellular permeability
when compared with those treated with lower doses or
carrier control (Figure 5A). In addition, 2-week-old mice
treated with high-dose LGG (live or heat killed) exhibited
intestinal permeability similar to that of 3-week-old con-
ventionally reared controls, suggesting that early probi-
otic administration can accelerate developmental barrier
maturation. Furthermore, although treatment with live
high-dose LGG (1  109 CFU) was associated with in-
creased mortality, high-dose heat-killed treatment was
not (Figure 5B). Finally, LGG treatment (1  109 CFU)
A
CLDN3
OCLN
B
Figure 4. Maturation of intestinal claudin 3 expression and barrier function
(control), MyD88/, or antibiotic-raised (Abx) 3-week-old mice. Top pane
Expression of CLDN3 and occludin (OCLN) protein by immunoblot in murin
3 in wild-type (control), MyD88/, or antibiotic-raised 3-week-old mice, a
three experimental repeats per condition. D: Intestinal permeability, as mea
MyD88/, or antibiotic-raised 3-week-old mice. Data are the mean  SEMresulted in a twofold induction of claudin 3 intestinalmRNA expression (Figure 6A) and increased expression
of claudin 3 by immunofluorescent microscopy (Figure
6B), suggesting that claudin 3 may play a pivotal role in
probiotic-induced barrier maturation. In addition, we pro-
vide a potential mechanism by which LGG is able to
reduce intestinal permeability.
Discussion
Impaired intestinal barrier function has been impli-
cated in the pathogenesis of many intestinal inflamma-
tory syndromes, such as infectious enteritis, IBD,1,2 and
NEC.3,4,48,49 Thus, investigations aimed at understand-
ing the mechanisms behind the postnatal maturation of
intestinal barrier function are critical to developing pre-
ventative clinical strategies to reduce the incidence or
severity of these devastating diseases. Commensal bac-
teria up-regulate expression of genes that control intes-
tinal barrier function.18 In this study, we show that the
gene expression of multiple intestinal epithelial TJ pro-
teins is developmentally regulated, with key changes oc-
curring at 2 to 3 weeks of life and coincident with the
acquisition of enteric flora in neonatal mice.17
Developmentally deficient TJ protein expression may
contribute to the barrier dysfunction that predisposes to
intestinal inflammatory diseases seen in preterm new-
borns. In this study, the developmental survey of TJ pro-
teins implicated claudin 3 as the most transcriptionally
up-regulated TJ protein during an important period of
postnatal development. The maturation of claudin 3 pro-
tein expression and localization in murine intestinal epi-
thelia occurred simultaneously with maturation of intesti-
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claudin 3 in developmental maturation of barrier function
because it is an important tightening claudin that is highly
expressed in the mature adult intestine,50,51 although its
role in the developing intestine remains unclear. Claudin
3 expression is also altered in experimental NEC,28 and
loss of intestinal claudin 3 with urinary detection is asso-
ciated with intestinal injury in humans and rodents52 and
can be used as a biomarker for early diagnosis and
determination of the severity of NEC in premature neo-
nates.53 Previous reports28,29 demonstrate increased in-
testinal claudin 3 in a rodent model of experimental NEC.
However, whether increased intestinal claudin 3 occurs
as a response to intestinal injury or predisposes to intes-
tinal injury has not been clear. Our data strongly support
the role of claudin 3 as a tightening TJ protein that aids in
sealing of the paracellular intestinal barrier, and impaired
expression may play a role in predisposition to intestinal
disease. Thus, we suspect that increased intestinal clau-
din 3 expression may be an attempt by the host to repair
the epithelial barrier during intestinal injury. The transition
of claudin 3 localization from the crypt to villus, occurring
at 3 weeks postnatal age, may be critical in establishing
a more selective paracellular barrier. Coupled with this
transition is increased basolateral expression of claudin
3, although the specific role of basolateral expression of
select claudins remains unclear. Potential functions of
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Figure 5. LGG accelerates barrier maturation. A: Intestinal permeability in
2-week-old mice, as measured by serum FD4 concentration (5 hours after
oral gavage) in mice fed PBS alone (control) or with live (1  107 to 1  109
CFU) or heat-killed (1  109 CFU) LGG for 1 week. Intestinal permeability
was compared with 3-week-old conventionally raised (CR) mice as a refer-
ence point for mature intestinal barrier function. Data are the mean  SEM
from at least three independent experiments. *P  0.05, **P  0.01. B:
Kaplan-Meier survival curve for the same experimental groups as described
in A. The percentage survival and the number of mice per group are indi-
cated. ***P  0.001 by log-rank Mantel-Cox test.basolaterally expressed claudins include serving as apool for functional claudins as TJs undergo assembly
and disassembly and involvement in cell signaling.54,55
Because MyD88/ and antibiotic-raised mice dem-
onstrate increased intestinal permeability and reduced
claudin 3 expression at 3 weeks of life compared with
wild-type mice, commensal bacteria may play a key role
in the developmental regulation of intestinal barrier func-
tion. Although antibiotic-raised mice demonstrated a
trend toward increased permeability, variability in gut
barrier function in this group may be the result of host-
specific changes in intestinal flora. Prior studies56 have
demonstrated that altering the normal commensal colo-
nization of rat pups by the administration of antibiotics to
pregnant rats alter both postnatal intestinal growth and
barrier properties.
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Figure 6. LGG induces claudin 3 expression. A: Relative intestinal mRNA
expression of claudin 3, as assayed by quantitative real-time RT-PCR in mice
gavage fed PBS alone (control) or with LGG for 1 week. Intestines were
harvested at the age of 2 weeks. Data are the mean SEM from at least three
experimental repeats per condition. *P  0.05 versus control. B: Immuno-
fluorescent localization of claudin 3 in mice treated with PBS alone (control)
9or with LGG (1  10 CFU) for 1 week. Top panels: claudin staining alone
(green). Bottom panels: Nuclear counterstain (blue).
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may play a significant role in claudin 3–dependent bar-
rier maturation. However, the signaling pathways linking
TLR activation and claudin 3 expression in the develop-
ing intestine remain poorly understood and are an area
for future study. Interestingly, maturation of intestinal per-
meability (3 weeks) seems to occur approximately 1
week after acquisition of commensal flora (2 weeks) in the
mouse. Similarly, increased barrier function in response
to the probiotic LGG occurred after 1 week of treatment in
our studies. These data suggest that the use of probiotics
clinically to modulate intestinal barrier function may be
most effective in preventing, rather than treating, disease.
Probiotics remain a promising therapy in intestinal dis-
eases, particularly those that affect the immature epithe-
lia of preterm human intestines. Given that an immature
intestinal barrier likely plays a role in the pathogenesis of
NEC,57,58 probiotics may restore or replace essential
strains of commensal flora necessary for barrier matura-
tion in a preterm gut that is impaired by delayed com-
mensal colonization and low bacterial diversity.59 Lacto-
bacillus species specifically appear to be a critically
sensitive commensal that is lacking in preterm infants
and is also more susceptible to eradication in response to
antibiotic treatment and stress.59 Lactobacillus species
have reduced Rotaviral-induced increases in intestinal
permeability in immature suckling rats,60 and previous
groups have demonstrated the therapeutic potential of
both live36 and heat-killed LGG on reducing inflammation
in immature epithelia.61 In our study, up-regulation of
claudin 3 expression by LGG treatment was associated
with acceleration in the developmental maturation of the
intestinal barrier. Whether probiotic-induced up-regula-
tion of claudin 3 expression and barrier maturation can
reduce or prevent infectious enteritis, NEC, or IBD exper-
imentally remains an area of future investigation. Al-
though results from both human trials and experimental
animal models have generated encouraging data regard-
ing the beneficial effects of probiotics in reducing NEC
incidence and severity, the widespread use of probiotic
therapy is limited by concerns regarding adverse effects,
such as sepsis.62,63 These concerns parallel our findings
in which mice treated with high-dose LGG demonstrate
significantly increased mortality. The risks of administra-
tion of live bacteria to an intestine with an immature epi-
thelial barrier are particularly relevant in our study. We
demonstrated increased mortality when 1-week-old mice
were treated with live high-dose LGG (1  109 CFU/day
for 7 days). Our data indicate that mice 3 weeks old
have a leaky intestinal paracellular barrier. This immature
neonatal intestinal epithelial barrier may be permeable to
bacteria or bacterial products, which, in turn, may cause
increased morbidity and mortality if bacteria penetrate
the epithelial barrier. Supporting this idea, we gavage fed
2-week-old mice with fluorescently labeled LGG, and
demonstrated multiple bacteria crossing the intestinal
epithelial barrier into the lamina propria (see Supplemen-
tal Figure S2 at http://ajp.amjpathol.org). Similar concerns
regarding appropriate dosing of probiotic strains are
highlighted in a recent study,64 in which preterm piglets
treated with high doses of live probiotic strains devel-oped a higher incidence of NEC. Promisingly, we reca-
pitulated the positive effect of live high-dose LGG with
heat-killed LGG while avoiding the associated mortality.
This supports the therapeutic use of either purified or
nonviable bacterial products that may replicate the ben-
eficial effects of live probiotics without the associated
risks.
In conclusion, these data provide evidence that com-
mensal and probiotic bacteria play a key role in the
developmental maturation of the intestinal barrier by reg-
ulating claudin 3 protein expression. More important, our
data indicate that probiotic administration can accelerate
the maturation of both claudin 3 protein expression and
intestinal barrier function in an immature gut lacking com-
mensal bacteria. Thus, one mechanism by which probi-
otics may prevent intestinal diseases affecting neonates
and children is by inducing maturation of claudin 3 pro-
tein-regulated intestinal epithelial permeability. Further-
more, our study highlights the importance of exercising
caution when considering the therapeutic use of live pro-
biotics in hosts with immature or compromised barrier
function. Heat-killed probiotics may be a promising alter-
native to live bacteria as a therapy with significantly less
risk for adverse outcomes. Future studies aimed at inves-
tigating the signaling pathways stimulated by probiotic
bacteria that can regulate intestinal TJ protein expression
and barrier function may aid in the development of tar-
geted therapies to prevent or reduce the severity of infant
and childhood intestinal inflammatory syndromes.
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